Novartis copy of Amgen biotech drug shows similar efficacy-study

ZURICH (Reuters) - Novartis said its copycat version of Amgen's Neupogen for patients with low white blood cell counts works as well as the original drug in a late-stage trial.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news